drugset / Trial / NCT00733317

Budesonide for Emergency Treatment of Acute Wheezing in Children

NCT00733317

Phase 4 Completed 100 enrolled Kecioren Education and Training Hospital
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to determine if adding nebulized budesonide to the systemic steroid for treatment of acute wheezing has any additive benefit in the emergency room.

Timeline

Start
2007-09
Primary completion
2009-12
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budesonide Small molecule 0.5 mg/ml Inhaled

Indications